Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryoport (CYRX) Raw Materials (2018 - 2025)

Cryoport (CYRX) has disclosed Raw Materials for 8 consecutive years, with $15.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Raw Materials rose 4.5% to $15.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.3 million, a 4.5% increase, with the full-year FY2025 number at $15.3 million, up 4.5% from a year prior.
  • Raw Materials was $15.3 million for Q4 2025 at Cryoport, up from $14.4 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $18.3 million in Q4 2022 to a low of $8.3 million in Q1 2021.
  • A 5-year average of $14.5 million and a median of $14.7 million in 2024 define the central range for Raw Materials.
  • Peak YoY movement for Raw Materials: soared 87.64% in 2022, then fell 20.46% in 2024.
  • Cryoport's Raw Materials stood at $11.8 million in 2021, then surged by 54.37% to $18.3 million in 2022, then decreased by 16.14% to $15.3 million in 2023, then fell by 4.69% to $14.6 million in 2024, then grew by 4.5% to $15.3 million in 2025.
  • Per Business Quant, the three most recent readings for CYRX's Raw Materials are $15.3 million (Q4 2025), $14.4 million (Q3 2025), and $13.8 million (Q2 2025).